Asset 2 Conferences
Dotti, Gianpietro - VIB Conferences

Gianpietro Dotti

Lineberger Comprehensive Cancer Center / University of North Carolina at Chapel Hill, US
Biography

Dr. Dotti studied immunotherapy strategies to treat patients with hematologic malignancies including lymphomas and leukemia and solid tumors making use of chimeric antigen receptor (CAR). Dr Dotti has developed preclinical and clinical studies using CAR-redirected T cells. A significant focus of Dr Dotti research is the development of strategies of T cell engineering aimed at overcoming immune suppressive mechanisms of the tumor microenvironment.